NCT00617799 2023-10-10Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic MelanomaUniversity of NebraskaCompleted15 enrolled
NCT01388569 2017-05-17Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With SargramostimEastern Cooperative Oncology GroupCompleted48 enrolled